SHG · Healthcare

Starlake Bioscience Co Inc Zhaoqing Guangdong (600866)

Biotechnology

Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 600866

P/E ratio
25.00

Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — FAQ

What is 600866's P/E ratio?

The price-to-earnings (P/E) ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) is 25.00 (data as of 2026-05-24).

Does Starlake Bioscience Co Inc Zhaoqing Guangdong pay a dividend?

Dividend yield is not available in the current snapshot for Starlake Bioscience Co Inc Zhaoqing Guangdong (600866). Check the MyAverix Finance app for the latest dividend data.

What sector is Starlake Bioscience Co Inc Zhaoqing Guangdong in?

Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 600866 listed on?

600866 is listed on SHG.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play